These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 24535238)

  • 21. Transferability and within- and between-laboratory reproducibilities of EpiSensA for predicting skin sensitization potential in vitro: A ring study in three laboratories.
    Mizumachi H; Sakuma M; Ikezumi M; Saito K; Takeyoshi M; Imai N; Okutomi H; Umetsu A; Motohashi H; Watanabe M; Miyazawa M
    J Appl Toxicol; 2018 Sep; 38(9):1233-1243. PubMed ID: 29722446
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Assessment of the skin sensitization potency of eugenol and its dimers using a non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Noda S; Yamazaki S; Kakishima H; Yamasaki K; Kimber I
    J Appl Toxicol; 2004; 24(1):77-81. PubMed ID: 14745850
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Novel approach for classifying chemicals according to skin sensitizing potency by non-radioisotopic modification of the local lymph node assay.
    Takeyoshi M; Iida K; Shiraishi K; Hoshuyama S
    J Appl Toxicol; 2005; 25(2):129-34. PubMed ID: 15744759
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The local lymph node assay and the assessment of relative potency: status of validation.
    Basketter DA; Gerberick F; Kimber I
    Contact Dermatitis; 2007 Aug; 57(2):70-5. PubMed ID: 17627643
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Correlation between experimental human and murine skin sensitization induction thresholds.
    Api AM; Basketter D; Lalko J
    Cutan Ocul Toxicol; 2015; 34(4):298-302. PubMed ID: 25430073
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Application of BALB/c mouse in the local lymph node assay:BrdU-ELISA for the prediction of the skin sensitizing potential of chemicals.
    Hou F; Xing C; Li B; Cheng J; Chen W; Zhang M
    J Pharmacol Toxicol Methods; 2015; 72():53-8. PubMed ID: 25600862
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Predicting skin sensitizer potency based on in vitro data from KeratinoSens and kinetic peptide binding: global versus domain-based assessment.
    Natsch A; Emter R; Gfeller H; Haupt T; Ellis G
    Toxicol Sci; 2015 Feb; 143(2):319-32. PubMed ID: 25338925
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Use of IL-18 production in a human keratinocyte cell line to discriminate contact sensitizers from irritants and low molecular weight respiratory allergens.
    Corsini E; Mitjans M; Galbiati V; Lucchi L; Galli CL; Marinovich M
    Toxicol In Vitro; 2009 Aug; 23(5):789-96. PubMed ID: 19397996
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The impact of vehicle on the relative potency of skin-sensitizing chemicals in the local lymph node assay.
    Jowsey IR; Clapp CJ; Safford B; Gibbons BT; Basketter DA
    Cutan Ocul Toxicol; 2008; 27(2):67-75. PubMed ID: 18568891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. LLNA variability: An essential ingredient for a comprehensive assessment of non-animal skin sensitization test methods and strategies.
    Hoffmann S
    ALTEX; 2015; 32(4):379-83. PubMed ID: 26168096
    [TBL] [Abstract][Full Text] [Related]  

  • 31. SENS-IS, a 3D reconstituted epidermis based model for quantifying chemical sensitization potency: Reproducibility and predictivity results from an inter-laboratory study.
    Cottrez F; Boitel E; Ourlin JC; Peiffer JL; Fabre I; Henaoui IS; Mari B; Vallauri A; Paquet A; Barbry P; Auriault C; Aeby P; Groux H
    Toxicol In Vitro; 2016 Apr; 32():248-60. PubMed ID: 26795242
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Characterization of dermal sensitization potential for industrial or agricultural chemicals with EpiSensA.
    Mizumachi H; LeBaron MJ; Settivari RS; Miyazawa M; Marty MS; Sakaguchi H
    J Appl Toxicol; 2021 Jun; 41(6):915-927. PubMed ID: 33124094
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of a new in vitro skin sensitization assay (Epidermal Sensitization Assay; EpiSensA) using reconstructed human epidermis.
    Saito K; Nukada Y; Takenouchi O; Miyazawa M; Sakaguchi H; Nishiyama N
    Toxicol In Vitro; 2013 Dec; 27(8):2213-24. PubMed ID: 23999411
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A new in vitro method for identifying chemical sensitizers combining peptide binding with ARE/EpRE-mediated gene expression in human skin cells.
    McKim JM; Keller DJ; Gorski JR
    Cutan Ocul Toxicol; 2010 Sep; 29(3):171-92. PubMed ID: 20491607
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Use of the local lymph node assay for the estimation of relative contact allergenic potency.
    Basketter DA; Balikie L; Dearman RJ; Kimber I; Ryan CA; Gerberick GF; Harvey P; Evans P; White IR; Rycroft RJ
    Contact Dermatitis; 2000 Jun; 42(6):344-8. PubMed ID: 10871098
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A fluorescence high throughput screening method for the detection of reactive electrophiles as potential skin sensitizers.
    Avonto C; Chittiboyina AG; Rua D; Khan IA
    Toxicol Appl Pharmacol; 2015 Dec; 289(2):177-84. PubMed ID: 26455772
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A chemical dataset for evaluation of alternative approaches to skin-sensitization testing.
    Gerberick GF; Ryan CA; Kern PS; Dearman RJ; Kimber I; Patlewicz GY; Basketter DA
    Contact Dermatitis; 2004 May; 50(5):274-88. PubMed ID: 15209809
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemical applicability domain of the Local Lymph Node Assay (LLNA) for skin sensitisation potency. Part 2. The biological variability of the murine Local Lymph Node Assay (LLNA) for skin sensitisation.
    Roberts DW; Api AM; Aptula AO
    Regul Toxicol Pharmacol; 2016 Oct; 80():255-9. PubMed ID: 27470439
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Skin sensitization potency of methyl methacrylate in the local lymph node assay: comparisons with guinea-pig data and human experience.
    Betts CJ; Dearman RJ; Heylings JR; Kimber I; Basketter DA
    Contact Dermatitis; 2006 Sep; 55(3):140-7. PubMed ID: 16918612
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Dimethylfumarate: potency prediction and clinical experience.
    Basketter DA; White IR; Burleson FG; Burleson GR; Kimber I
    Contact Dermatitis; 2013 May; 68(5):269-72. PubMed ID: 23586478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.